scispace - formally typeset
M

M.W. Büchler

Researcher at Heidelberg University

Publications -  703
Citations -  28418

M.W. Büchler is an academic researcher from Heidelberg University. The author has contributed to research in topics: Pancreatitis & Pancreatic cancer. The author has an hindex of 67, co-authored 696 publications receiving 25796 citations. Previous affiliations of M.W. Büchler include University Hospital Heidelberg & University of Bern.

Papers
More filters
Journal ArticleDOI

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

TL;DR: In this article, an international panel of pancreatic surgeons, working in well-known, high-volume centers, reviewed the literature on the topic and worked together to develop a simple, objective, reliable, and easy-to-apply definition of postoperative pancreatic fistula, graded primarily on clinical impact.

Special article Postoperative pancreatic fistula: An international study group (ISGPF) definition

TL;DR: The present definition and clinical grading of POPF should allow realistic comparisons of surgical experiences in the future when new techniques, new operations, or new pharmacologic agents that may impact surgical treatment of pancreatic disorders are addressed.
Journal ArticleDOI

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After

TL;DR: This new definition and grading system of postoperative pancreatic Fistula should lead to a more universally consistent evaluation of operative outcomes after pancreatic operation and will allow for a better comparison of techniques used to mitigate the rate and clinical impact of a pancreatic fistula.
Journal ArticleDOI

Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.

TL;DR: Activated PSCs are present in theStromal reaction in pancreatic cancers and are responsible for the production of stromal collagen.
Journal Article

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

TL;DR: Among patients with resected periampullary adenocarcinoma, adjuvant chemotherapy, compared with observation, was not associated with a significant survival Benefit in the primary analysis; however, multivariable analysis adjusting for prognostic variables demonstrated a statistically significant survival benefit associated with adjuant chemotherapy.